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Neurobiology of Disease

␥-Secretase Composed of PS1/Pen2/Aph1a Can Cleave Notch
and Amyloid Precursor Protein in the Absence of Nicastrin
Guojun Zhao,1 Zhenyi Liu,1 Ma. Xenia G. Ilagan,1 and Raphael Kopan1,2
1

Department of Developmental Biology, and 2Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110

␥-Secretase is a multiprotein, intramembrane-cleaving protease with a growing list of protein substrates, including the Notch receptors
and the amyloid precursor protein. The four components of ␥-secretase complex—presenilin (PS), nicastrin (NCT), Pen2, and Aph1—
are all thought to be essential for activity. The catalytic domain resides within PS proteins, NCT has been suggested to be critical for
substrate recognition, and the contributions of Pen2 and Aph1 remain unclear. The role of NCT has been challenged recently by the
observation that a critical residue (E332) in NCT, which had been thought to be essential for ␥-secretase activity, is instead involved in
complex maturation. Here, we report that NCT is dispensable for ␥-secretase activity. NCT-independent ␥-secretase activity can be
detected in two independent NCT-deficient mouse embryonic fibroblast lines and blocked by the ␥-secretase inhibitors N-[N-(3,5difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester and L-685,458. This catalytic activity requires prior ectodomain shedding of the
substrate and can cleave ligand-activated endogenous Notch receptors, indicating presence of this activity at the plasma membrane. Small
interfering RNA knockdown experiments demonstrated that NCT-independent ␥-secretase activity requires the presence of PS1, Pen2, and
Aph1a but can tolerate knockdown of PS2 or Aph1b. We conclude that a PS1/Pen2/Aph1a trimeric complex is an active enzyme, displaying
biochemical properties similar to those of ␥-secretase and roughly 50% of its activity when normalized to PS1 N-terminal fragment levels. This
PS1/Pen2/Aph1a complex, however, is highly unstable. Thus, NCT acts to stabilize ␥-secretase but is not required for substrate recognition.

Introduction
␥-Secretase is a multiprotein, intramembrane-cleaving protease
that cleaves its substrates within their transmembrane domains
(TMDs) (Selkoe and Kopan, 2003). Biologically and clinically
important ␥-secretase substrates (Fagan et al., 2007; Selkoe and
Wolfe, 2007; Dejaegere et al., 2008) include amyloid precursor
protein (APP) (Haass, 2004; Thinakaran and Koo, 2008; Wolfe,
2008), ErbB4 (Ni et al., 2001), neuregulin (Bao et al., 2003), and
the Notch receptors (De Strooper et al., 1999). The physiological
and pathological roles of ␥-secretase, its potential as a drug target
in cancer and Alzheimer’s disease (Miele et al., 2006; Roy et al.,
2007; Aster et al., 2008; Tomita, 2009), and its novel function as
an intramembrane-cleaving protease have generated intense
commercial and academic interest in this mysterious enzyme. A
better understanding of its structure, substrate recognition, and
regulation will improve therapeutic exploitation of this complex
protease (Kukar et al., 2008; Wolfe, 2009).
Genetic and biochemical studies have provided strong evidence that ␥-secretase is a multiprotein complex comprised of
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presenilin (PS; either PS1 or PS2), which contains the catalytic
site (De Strooper et al., 1998; Wolfe et al., 1999; Li et al., 2000);
nicastrin (NCT), which is thought to contain a substrate binding
site (Shah et al., 2005); and Pen2 and Aph1 (1a, 1b, or 1c in
rodents), which are of unclear contribution (De Strooper, 2003;
Iwatsubo, 2004). Loss of any of these four proteins seemed to
abolish ␥-secretase activity (Francis et al., 2002; Takasugi et al.,
2003), and only coexpression of the four components together
reconstitutes ␥-secretase activity in yeast (Edbauer et al., 2003) or
SF9 cells (Hayashi et al., 2004), both of which lack endogenous
␥-secretase activity. Consistent with the existence of several distinct ␥-secretases, the active enzyme contains four components,
each with potentially unique properties (Serneels et al., 2009).
PS is the founding member of a novel GxGD-type aspartyl
protease family that includes the prokaryotic type IV prepilin
peptidase (TFPP) and the eukaryotic signal peptide peptidase
(SPP) and SPP-like proteases (SPPLs) (Haass and Steiner, 2002).
In contrast to PS, TFPP, SPP, and SPPL proteins are single-chain
enzymes, performing their activity without additional partners
(Golde et al., 2009; Wolfe, 2009). It is still unclear why PS needs
several cofactors. The precise role for NCT within ␥-secretase has
been controversial. NCT may facilitate substrate recognition
(Shah et al., 2005; Dries et al., 2009) or may instead act to stabilize
the ␥-secretase complex (Shirotani et al., 2004; Zhang et al.,
2005); a critical residue thought to be involved in substrate recognition (E332) was shown to be essential for ␥-secretase maturation but not for its activity in mouse cells (Chavez-Gutierrez et
al., 2008). Thus, the exact role of NCT remains controversial.
To elucidate the contribution of NCT to ␥-secretase, we analyzed ␥-secretase activity in two independent NCT knock-out cell
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plemented with 10% fetal bovine serum (FBS)
was added to neutralize the trypsin/EDTA, and
the cells were further dissociated by pipetting,
plated into 24-well plates, and subsequently immortalized with polyoma large T antigen. Immortalized NCT knock-out clones were
confirmed by both genotyping and Western blot
analysis.
Cell culture and plasmid transfection. For
most experiments, cells were maintained in
DMEM supplemented with 10% FBS, 2 mM
glutamine and incubated at 37°C and 5% CO2.
To examine the generation of Notch intracellular domain (NICD) and amyloid intracellular domain (AICD), cells were transfected with
pCS2⫹/N1⌬E-6MT and pCS2⫹/C99-6MT
vectors or empty vector using Lipofectamine
2000 (Invitrogen) or FuGENE HD (Roche)
transfection reagents, according to the manufacturers’ instructions. The transfected cells
were subsequently cultured in the presence or
absence of proteasome inhibitors (4.5 M lactacystin/0.15 M MG262; Calbiochem) and
␥-secretase inhibitors [either 1 M N-[N-(3,5difluorophenacetyl-L-alanyl)]-S-phenylglycine
t-butyl ester (DAPT) or 1  M L-685,458;
Calbiochem].
A␤ analysis. pCS2⫹/C99-6MT-transfected
cells were cultured in OPTI-MEM supplemented with 7% FBS, 2 mM glutamine, 10 mM
nonessential amino acids, 10 M phosphoramidon disodium (Sigma), with or without proteasome inhibitors and ␥-secretase inhibitors.
Both cells and conditioned media (CMs) were
collected 20 –22 h later. The CMs were supplemented with 1 mM AEBSF [4-(2-aminoethyl)
Figure 1. NICD is generated by a GSI-sensitive activity in NCT ⫺/⫺ cells but not in PS DKO cells. Representative Western blots of benzenesulfonyl fluoride hydrochloride; Roche],
NICD levels in pCS2⫹/N1⌬E-6MT-transfected NCTPW⫹/⫹, NCTPW⫺/⫺, and PS DKO cells are shown. A, Schematic representation of centrifuged, and analyzed by A␤ ELISA (InNotch C-terminal fragments (CTFs). TMIC (transmembrane/intracellular), NEXT, and NICD denote Notch CTFs generated after S1, vitrogen) according to the manufacturer’s inS2, and S3 site cleavages, respectively. B, Cells were transiently transfected with pCS2⫹/N1⌬E-6MT or pCS2⫹ empty vector. structions, but with a slight modification. The
N1⌬E-6MT does not contain the extracellular domain, thereby making it a ligand-independent, direct substrate of ␥-secretase. incubation time for antibodies and stabilized
NICD accumulated in both NCTPW⫹/⫹ and NCTPW⫺/⫺ cells cultured in the presence of proteasome inhibitors (lactacystin/MG262) chromogen and the time for each wash step
but not in PS DKO cells; DAPT and L-685,458 blocked NICD generation. NCTm and NCTim denote mature and immature forms of NCT, were increased to make testing lower levels of
A␤ more accurate. Each sample was run in durespectively. FL-PS1, Full-length PS1.
plicate. The CMs from cells transfected with
empty vector were used as blanks.
lines. We found that a complex containing PS1, Pen2, and Aph1a
Coculture of NCTRR⫺/⫺ cells with ligand-expressing cells. NCTRR⫺/⫺ or
could cleave Notch and APP at the same sites used by holo-␥PS DKO cells were coseeded with either CHO-DLL1-IRES-GFP (CHO:
secretase. The presence of catalytic activity demonstrated unChinese hamster ovary; IRES: internal ribosome entry site; GFP: green
equivocally that NCT is not required for ␥-secretase substrate
fluorescent protein) or CHO-GFP control cells (these two cell lines have
been described previously) (Ong et al., 2008), cultured for 24 h, and then
recognition, instead acting mainly to stabilize ␥-secretase.
treated with or without lactacystin/MG262 and DAPT. The cells were
collected after 20 h and lysed with lysis buffer A containing 8 M urea, 1%
Materials and Methods
SDS, 50 mM Tris-HCl, pH 6.8, 2 mM EDTA, 2 mM DTT, and 1⫻ protease
Plasmids. pCS2⫹/N1⌬E-6MT, pCS2⫹/C99-6MT, and pcDNA3/PS1wt
inhibitor cocktail (Roche) (Zhao et al., 2004).
vectors have been described previously (Kopan et al., 1996; Schroeter et
siRNA transfection. ON-TARGETplus small interfering RNA (siRNA)
al., 2003).
smart pools targeting mouse PS1, PS2, Pen2, Aph1a, and Aph1b were
Cell lines. NCT-deficient Ncstn tm1Pcw/Ncstn tm1Pcw (NCTPW⫺/⫺)
purchased from Dharmacon (see supplemental Table 1, available at
and wild-type (NCTPW⫹/⫹) mouse embryonic fibroblast (MEF) lines
www.jneurosci.org as supplemental material for sequences). ONwere generous gifts from Dr. Philip C. Wong (Johns Hopkins University,
TARGETplus nontargeting siRNA control (Dharmacon) was used as a negBaltimore, MD) (Li et al., 2003). PS1/PS2 double knock-out (PS DKO)
ative control. siRNAs were transfected into NCT ⫺/⫺ cells using
and PS1/PS2 wild-type (PS⫹/⫹) MEF lines were generous gifts from Dr.
DharmaFect 1 (Dharmacon) according to the manufacturer’s inBart De Strooper (Katholieke Universiteit Leuven, Leuven, and Flanders
structions. The cells were cultured in complete medium for 48 h and
Institute for Biotechnology, Leuven, Belgium) (Herreman et al., 1999).
then transfected with pCS2⫹/N1⌬E-6MT vector. Knockdown effiWe established Ncstn tm1Rroz/ Ncstn tm1Rroz MEF using NCT ⫹/⫺ breeders
ciency was determined by either Western blotting or quantitative
generously provided by Dr. Richard Rozmahel (University of Toronto,
reverse transcription (qRT)-PCR.
Toronto, Canada) (Nguyen et al., 2006) using a previously described
qRT-PCR. siRNA-transfected NCTRR⫺/⫺ cells were cultured for 68 h.
method (Li et al., 2003) but with a slight modification. Briefly, embryonic
The total RNA was then isolated using RNeasy Micro kit (Qiagen) acday (E)9.5 embryos were minced and resuspended in DMEM containing
0.025% trypsin/EDTA and incubated at 37°C for 20 min. DMEM supcording to the manufacturer’s instructions. The reverse transcription was
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performed using SuperScript II reverse transcriptase (Invitrogen) with oligo(dT)16 as the
primer. Quantitative PCR was performed according to previously described methods
(Lee et al., 2007) (see supplemental Table 2,
available at www.jneurosci.org as supplemental material for primer sequences).
EDTA treatment. NCTRR⫺/⫺, NCTPW⫺/⫺,
PS DKO, and PS⫹/⫹ cells were washed once with
HBSS buffer (without Ca or Mg) and incubated in 1.5 mM EDTA/HBSS buffer for 40 min
at 37°C. For ␥-secretase inhibition, cells were
treated with 1 M DAPT for 4 h before and
during EDTA incubation.
Western blotting and antibodies. Cells were
lysed in lysis buffer A with brief sonication, and
the protein concentration was determined using a BCA kit (Pierce). Twenty to 30 g of total
protein per sample was analyzed by SDSPAGE/Western blot analysis. The following antibodies were used in this study: anti-V1744 (Cell
Signaling Technology), anti-NCT (N1660,
Sigma), anti-PS1-NTF (Santa Cruz Biotechnology), anti-PS2-CTF antibodies B24.2 and
G2L [generous gifts from Dr. Bart De Strooper
(Herreman et al., 1999) and Dr. Taisuke Tomita (Tomita et al., 1998), respectively], antiAph1a (Covance), anti-Notch1 ANK domain
(mAN1) (Huppert et al., 2000), anti-␤-actin
(Sigma), and anti-myc (9E10).

Results

ⴚ/ⴚ

Figure 2. Generation of NICD is observed in two independent NCT ⫺/⫺ lines. Representative Western blots of NICD levels
generated in pCS2⫹/N1⌬E-6MT-transfected NCTPW⫺/⫺, NCTRR⫺/⫺, NCTPW⫹/⫹, and PS⫹/⫹ cells are shown. NICD was detected
in both NCTPW⫺/⫺ and NCTRR⫺/⫺ lysates and was blocked by the ␥-secretase inhibitor L-685,458. Because NCTRR⫺/⫺ cells
express less N1⌬E-6MT compared with other cell lines, a longer exposure was used for detecting NICD. The two wild-type MEF lines
(NCTPW⫹/⫹ and PS⫹/⫹) and wild-type MEFs isolated from littermates of NCTRR⫺/⫺ mice displayed similar ␥-secretase activity
(lanes 5– 8, 13–16, and data not shown). FL-PS1, Full-length PS1.

DKO

NICD is generated in NCT
cells but not in PS
cells
All GxGD proteases prefer substrates that have undergone
ectodomain shedding, and all, including PS, contain a substrate
recognition domain (Kornilova et al., 2005). We hypothesized
that if the role of NCT was to stabilize ␥-secretase, but not to bind
substrates, we should be able to detect ␥-secretase activity in the
absence of NCT. To test this hypothesis, we transiently transfected wild-type (NCTPW⫹/⫹) and NCTPW⫺/⫺ cells (from Dr.
P.C. Wong) with ectodomain-truncated, Notch1-expressing vector (pCS2⫹/N1⌬E-6MT). The truncated Notch1 ⌬E-6myc protein is a ligand-independent and direct substrate of ␥-secretase,
similar to Notch extracellular truncation (NEXT) (Fig. 1A). To
enhance detection, transfected cells were cultured in the presence
of proteasome inhibitors that reduce the turnover of the NICD
(Tagami et al., 2008) and increase the sensitivity of detection for
this cleavage product. Western blot analyses with an anti-myc
antibody indicated that N1⌬E-6MT expression levels in
NCTPW⫹/⫹ and NCTPW⫺/⫺ cells were equivalent and that proteasome inhibition increased the amounts of N1⌬E-6MT (Fig.
1 B, lanes 2, 5, and 6), presumably by decreasing degradation of
uncleaved molecules. Consistent with previous reports (Zhang et
al., 2005), we also observed PS1 N-terminal fragment (PS1-NTF)
in NCTPW⫺/⫺ cells, an indication that some presenilinase activity
remained (Fig. 1 B, lane 4). We then assessed N1⌬E-6MT cleavage between G1743-V1744 with an epitope-specific antibody (␣VLLS; i.e., V1744 antibody). When probed with anti-V1744
antibody, NICD was detected in NCTPW⫹/⫹ cells as expected.
Significantly, in the presence of proteasome inhibitors, PS1-NTF
and NICD accumulated in NCTPW⫺/⫺ cells (Fig. 1 B, lane 5). To
examine whether the NICD generated in NCTPW⫺/⫺ cells was
produced by an aspartyl protease, we asked whether this NCTindependent protease was sensitive to a selective ␥-secretase
inhibitor (GSI), DAPT (N-[N-(3,5-difluorophenacetyl-Lalanyl)]-S-phenylglycine t-butyl ester) (Weihofen et al., 2003).

DAPT completely abolished the generation of NICD in
NCTPW⫺/⫺ cells (Fig. 1 B, lane 6), suggesting that NICD is generated by a ␥-secretase-like activity in the absence of NCT. Generation of NICD in NCTPW⫺/⫺ cells was also blocked by a
structurally distinct GSI, L-685,458 (Fig. 1 B, lane 14). We therefore concluded that in the NCTPW⫺/⫺ cell line, Notch is cleaved at
the peptide bond between G1743 and V1744 [site 3 (S3)] by a
GSI-sensitive activity.
To our knowledge, ␥-secretase is the only enzyme that cleaves
Notch1 at its S3 site, but the existence of other enzymes with
␥-secretase-like activity has been proposed to compensate for PS
loss (Huppert et al., 2005). To ask whether a Notch intramembrane protease exists in other ␥-secretase-deficient cells, we examined NICD generation in PS DKO cells, which are deficient in
both PS1 and PS2. Western blot analyses showed that both PS DKO
and NCTPW⫺/⫺ cells expressed high levels of N1⌬E-6MT, yet
NICD was undetectable in samples from PS DKO cells under the
same conditions that allow NICD accumulation in NCTPW⫺/⫺
samples (Fig. 1 B, lanes 9 and 13). The generation of NICD in
PS DKO cells can be rescued by transfection of wild-type PS1 or
PS2 but not an inactive aspartyl mutant PS1, confirming that the
failure to generate NICD by PS DKO cells is not an indication of
other defects (supplemental Fig. 2, available at www.jneurosci.
org as supplemental material) (Schroeter et al., 2003). Overall, these
results indicate that a ␥-secretase-like activity in NCTPW⫺/⫺ cells
cleaves Notch to generate NICD and that this activity does not exist
in PS DKO cells.
Generation of NICD is observed in two independent
NCT ⴚ/ⴚ lines
We noticed a faint cross-reacting band with mobility similar to
that of immature NCT in NCTPW⫺/⫺ cells (Fig. 1 B). NCTPW⫺/⫺
cells were derived from an NCT knock-out embryo in which the
critical part of the DAP (DYIGS and peptidase homologous region) domain (exon 9, intron 9, and part of exon 10) was replaced
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␥-secretase-like activity is independent of
the specific NCT ⫺/⫺ line used.
Endogenous Notch can be cleaved by
the ␥-secretase-like activity in NCT ⴚ/ⴚ
cells but not in PS DKO cells
The ␥-secretase-like activity that survived
removal of NCT may only cleave ectopically expressed Notch substrates lacking
an extracellular domain. To ask whether
this enzyme could cleave endogenous
Notch, we examined the cleavage of endogenous Notch1 receptors under conditions that induce ectodomain shedding at
the cell surface. In the absence of ligands, a
calcium-stabilized negative regulatory region prevents metalloprotease access to
the S2 cleavage site (Gordon et al., 2007).
Ligand binding or treatment with EDTA
(Rand et al., 2000) is thought to result in a
conformational change that leads to the
exposure of the S2 cleavage site and subsequent cleavage by ADAM (a disintegrin
and metalloproteinase) metalloproteases
(Kopan and Ilagan, 2009), generating
NEXT (Fig. 1 A), a direct substrate of
␥-secretase. Western blot analyses showed
that all the MEF lines (except for
NCTPW⫺/⫺) expressed endogenous Notch1.
To test whether the generation of NICD
from endogenous Notch1 can occur without NCT protein, PS DKO cells and
NCTPW⫺/⫺, NCTRR⫺/⫺, and wild-type
MEFs were treated with or without EDTA
to induce S2 cleavage (see shift in mobility
⫺/⫺
DKO
Figure 3. NICD is generated from endogenous Notch1 in NCT
cells but not in PS cells. A, Representative Western blots in Fig. 3A). Importantly, after treatment
of NICD levels in EDTA-treated cells. Metalloprotease-mediated shedding occurs after calcium chelation-induced dissociation of with EDTA, DAPT-sensitive NICD gener⫺/⫺
and
endogenous Notch1. EDTA treatment led to reduced amounts of furin-cleaved Notch [transmembrane/intracellular (TMIC)] and ation was detected in NCTRR
increased amounts of NEXT, indicating that upon EDTA treatment Notch1 undergoes S2 site cleavage in PS DKO, NCTRR⫺/⫺, and wild-type cells (Fig. 3A, lanes 8 –9 and 11–
PS⫹/⫹ cells. Although endogenous Notch1 levels are similar in both PS DKO and NCTRR⫺/⫺ cells, NICD is produced from NEXT only 12). Moreover, after EDTA treatment, enin NCTRR⫺/⫺ (arrow) cells but not in PS DKO cells. NCTPW⫺/⫺ cells do not express endogenous Notch1. B, Representative Western dogenous NICD was observed in
blots of NICD levels in NCTRR⫺/⫺ cells cocultured with Notch ligand-expressing cells. NICD is generated in NCTRR⫺/⫺ cells from NCT ⫺/⫺ cells even without proteasome
endogenous Notch1 receptors after activation by ligands presented by neighboring cells. Note that NICD was only detected in inhibition (Fig. 3 A, B). This result concoculture of NCTRR⫺/⫺ cells with CHO-DLL1 cells but not in the other cocultures or CHO cells alone. DAPT treatment blocked the
firms that ectodomain shedding is regeneration of NICD. Long Exp., Long exposure; Short Exp., short exposure.
quired for the release of NICD in
NCTRR⫺/⫺ cells (Fig. 3A, compare lanes 7
with the neomycin resistance gene (Li et al., 2003). To test
and 8). In contrast, Notch1-expressing PS DKO cells accumulated
the S2 cleavage product NEXT but did not produce NICD (Fig.
whether ␥-secretase-like activity in this specific cell line was due
to residual NCT expression, we analyzed a second, independently
3A, lanes 1 and 2). Because removal of calcium with EDTA occurs
at or near the cell surface and because both ADAM10 and Notch1
generated NCT knock-out mouse line (from Dr. Richard Rozmahel) in which exon 3 and a part of exon 4 had been deleted, and
are mainly localized at the plasma membrane (van Tetering et al.,
therefore splicing downstream of the deletion would shift the read2009), this result suggests that the NCT-deficient ␥-secretase-like
protease performs its activity at or close to the plasma membrane.
ing frame (Nguyen et al., 2006). We isolated NCTRR⫺/⫺ MEF cells
from E9.5 NCTRR⫺/⫺ embryos and examined NCT production and
To obtain physiologically relevant evidence that ␥-secretase␥-secretase activity in these cells. No NCT immunoreactivity was
like activity reached the cell surface, we asked whether the Notch1
observed in NCTRR⫺/⫺ cell extracts (Fig. 2, lanes 9 –12). Imporreceptors in NCTRR⫺/⫺ cells could be activated by ligands pre⫺/⫺
⫺/⫺
tantly, as in NCTPW
sented on neighboring cells. We cocultured NCTRR⫺/⫺ (or concells, endoproteolysis of PS1 in NCTRR
was also observed, confirming that PS endoproteolysis does not retrol PS DKO cells) with either ligand-expressing (CHO-DLL1) or
control (CHO-GFP) cells in the presence or absence of proteaquire NCT. Accordingly, in the presence of proteasome inhibitors
some inhibitors. Western blot analysis shows that coculture with
we observed NICD accumulation in NCTRR⫺/⫺ cells (Fig. 2, lane
11). In this cell line, NICD production was again blocked by either
CHO-DLL1 cells induced endogenous Notch1 S2 cleavage (Fig.
L-685,458 (Fig. 2, lane 12) or DAPT (Fig. 3A). Overall, these data
3B). As expected, if the enzyme reached the cell surface, endogeclearly demonstrate that generation of NICD by residual
nous NICD was detected in NCTRR⫺/⫺ cells cocultured with
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CHO-DLL1 (Fig. 3B, lanes 8 and 9) but
not in NCTRR⫺/⫺ cells cocultured with
CHO-GFP. DAPT blocked the generation
of NICD in NCTRR⫺/⫺ cells (Fig. 3B,
lane10), and PS DKO cells cocultured with
CHO-DLL1 cells did not release NICD,
indicating that NICD was not generated
by the CHO cells (Fig. 3B, lanes 4, 5, 11,
and 12). Together, these results confirm
that the ␥-secretase-like activity in
NCT ⫺/⫺ cells requires substrate ectodomain shedding and can reach the plasma
membrane to mediate the cleavage of
ligand-activated Notch.
C99 is converted into AICD and A␤ in
NCT ⴚ/ⴚ cells but not in PS DKO cells
Another important substrate of ␥-secretase
is APP, which is involved in the pathogenesis of Alzheimer’s disease. Since mutations
in NCT were shown previously to differentially affect APP and Notch processing
(Chen et al., 2001), we asked whether a Figure 4. C99 is cleaved to generate AICD and A␤ in NCT ⫺/⫺ cells but not in PS DKO cells. A, Representative Western blots of
truncated APP substrate (C99) could be AICD levels in C99-6MT-transfected cells. PS DKO, NCTPW⫺/⫺, NCTRR⫺/⫺, and PS⫹/⫹ cells were transiently transfected with
processed in NCT ⫺/⫺ cells by the ␥-secretase- pCS2⫹/C99-6MT or empty vector and analyzed for AICD and A␤ generation. A DAPT-sensitive AICD-6Myc band was observed in
likeactivity.WetransientlytransfectedPS DKO, NCT ⫺/⫺ cells and wild-type MEFs but not in PS DKO cells. A ␥-secretase-independent, faster-migrating Myc-reactive band was
NCTPW⫺/⫺, NCTRR⫺/⫺, and wild-type MEF observed in all samples (it was not sensitive to DAPT and was generated in PS DKO cells). B, A␤40 is produced in NCT ⫺/⫺ cells but
DKO
cells with C99-6myc-expressing vector. West- not in PS cells. The CM from cells transfected with empty vector was used as the blank in the assay.
ern blot analyses confirmed that a DAPTciency of PS2 siRNA knockdown was confirmed by qRT-PCR
sensitive fragment (AICD-6myc) present in wild-type cells but not in
(Fig. 5B). Accordingly, cotransfection of PS1 siRNA together
PS DKO cells was also seen in two NCT-deficient cell lines (Fig. 4A, lanes
with PS2 siRNA did not further reduce NICD amounts (Fig. 5A,
3, 7, and 13), suggesting that NCT ⫺/⫺ cells are able to cleave C99 (Fig.
lanes 7 and 8). Similar results were obtained with NCTPW⫺/⫺ cells
4 A; note that proteasome inhibition was required to detect the
(supplemental Fig. 3, available at www.jneurosci.org as supplecleavage products). A longer exposure detected low amounts of
mental material). These results suggest that PS1 or a PS1AICD-myc in NCTPW⫺/⫺ cells not treated with proteasome incontaining enzyme in NCT ⫺/⫺ cells mediates NICD production.
hibitors (supplemental Fig. 1, available at www.jneurosci.org as
To ask whether PS2 can contribute to ␥-secretase activity in
supplemental material). To address whether A␤ was also pro⫺/⫺
⫺/⫺
NCT
cells, we overexpressed PS2 in NCTRR⫺/⫺ cells. We first
duced in NCT
cells, we performed ELISA analysis on condiperformed PS1 mRNA knockdown and then asked whether cotioned media to determine the secreted A␤ levels. A␤40 was detected
transfection of the substrate (pCS2⫹/N1⌬E-6MT) with either
in conditioned media from NCT ⫺/⫺ cells but not from PS DKO cells
human PS1 or PS2 expression vector into these mouse PS1(Fig. 4B) and was abolished after DAPT addition (Fig. 4B). We were
depleted NCT ⫺/⫺ cells would restore the ␥-secretase activity.
unable to detect A␤42 levels with the A␤42 ELISA kit, likely due to
While both PS1 and PS2 restored ␥-secretase activity equally well
the low transfection efficiency of MEF cells. Collectively, these data
in PS DKO cells, only human PS1, but not human PS2, restored
indicate that not only can the residual ␥-secretase activity cleave
␥-secretase activity in PS1 siRNA-transfected NCT ⫺/⫺ cells (supAPP, it can proceed from the -cleavage site to the ␥-cleavage site, a
plemental Fig. 2, available at www.jneurosci.org as supplemental
hallmark of ␥-secretase (Tanzi and Bertram, 2005; Haass and
material). These data confirmed that PS2 protein could not conSelkoe, 2007), even in the absence of NCT.
tribute to the ␥-secretase activity in NCT ⫺/⫺ cells.
ⴚ/ⴚ
␥-Secretase-like activity in NCT
cells is PS1 dependent
Pen2 and Aph1a are involved in the ␥-secretase-like activity
The fact that two unrelated ␥-secretase inhibitors abolished the
To ask whether PS1 acted as a single-molecule protease like SPP
␥-secretase-like activity in NCT ⫺/⫺ cell lines, and that PS DKO
(Golde et al., 2009), we examined whether Pen2 and Aph1 were
cells did not exhibit this activity, strongly implies that PS is the
still required for the PS1 activity in the absence of NCT. We
active enzyme in NCT ⫺/⫺ cells. To test this, we used siRNAs to
performed Pen2 or Aph1 knockdown in NCTRR⫺/⫺ cells using
knock down PS1 and PS2 (alone or together) in NCTRR⫺/⫺ cells
siRNA pools and confirmed the efficiencies of siRNA knockdown
transfected with N1⌬E-6MT. Western blot analysis confirmed
by qRT-PCR (Fig. 6 B, D). Western blot analyses demonstrated
that PS1 siRNA markedly decreased both full-length PS1 and
that knockdown of Pen2 did not decrease the amount of fullPS1-NTF (Fig. 5A, lanes 3 and 4), whereas control siRNA and PS2
length PS1 but dramatically reduced PS1-NTF levels and, consiRNA did not affect PS1 protein level (Fig. 5A, lanes 1, 2, 5, and
comitantly, the amounts of NICD (Fig. 6 A, lanes 3– 8). Of the
6). Interestingly, PS1 knockdown alone was sufficient to signifithree murine Aph1 genes (Ma et al., 2005; Serneels et al., 2005),
cantly diminish NICD production, whereas knockdown of PS2
only knockdown of Aph1a in NCTRR⫺/⫺ cells reduced PS1-NTF
did not show an obvious effect (Fig. 5A, lanes 5– 6). Since we
and NICD levels, whereas full-length PS1 levels remained uncould not detect PS2 in these cells with two different established
changed (Fig. 6C, lanes 3– 6). Aph1b siRNA did not impact PS1antibodies (Tomita et al., 1998; Herreman et al., 1999), the effi-
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as it was unstable in blue native gels (data not shown). Therefore,
we compared the relative activity of ␥-secretase in NCT ⫺/⫺ cells
and wild-type cells using a semiquantitative Western blot analysis
of extracts isolated from cells cultured in the presence of proteasome inhibitors. As shown in supplemental Figure 4 (available at
www.jneurosci.org as supplemental material), in cell lysates containing equivalent levels of PS1 NTF fragments, NCT ⫺/⫺ cells
produced 50 –55% of the NICD produced by wild-type lines.
From these data, we can conclude that the trimeric enzyme is
much more active than would be expected if NCT was providing
the substrate recognition function in the complex. We cannot
rule out an indirect contribution by NCT to overall activity due to
increased enzyme stability.

Discussion

Figure 5. ␥-Secretase-like activity in NCT ⫺/⫺ cells is PS1 dependent. A, Representative
Western blots of NICD levels in PS siRNA-transfected NCTRR⫺/⫺ cells. NCTRR⫺/⫺ cells were
transfected with PS1, PS2, PS1-plus-PS2, or nontargeting control siRNAs. The cells were subsequently transfected with pCS2⫹/N1⌬E-6MT and cultured in the presence of proteasome inhibitors. Cell lysates were then analyzed by Western blotting with antibodies against PS1NT,
Myc, V1744, and ␤-actin. PS1 siRNA markedly decreased both full-length PS1 (FL-PS1) and
PS1-NTF. Although the levels of N1⌬E-6myc are similar in every extract, NICD accumulation was
strikingly reduced in PS1 siRNA-transfected cells and in PS1-plus-PS2 siRNA-transfected cells
but not in siRNA control (Ctr)- or PS2 siRNA-transfected cells. B, Since the PS2 proteins in these
NCT ⫺/⫺ cells were undetectable by Western blot analysis using two well-characterized antiPS2 antibodies (data not shown), knockdown of PS2 was confirmed by qRT-PCR.

NTF or NICD level (Fig. 6C, lanes 7–10). Similar results were
obtained with NCTPW⫺/⫺ cells (supplemental Fig. 3, available at
www.jneurosci.org as supplemental material). These results suggest that in NCT ⫺/⫺ cells, an unstable ␥-secretase isomorph
composed of three proteins (PS1, Pen2, and Aph1a) provides
␥-secretase activity that correlates strongly with the amount of
endoproteolytically processed PS1-NTF but not full-length PS1.
Thus, PS1 activity requires endoproteolysis and the functions of
Pen2 and Aph1a.
Trimeric ␥-secretase retains 50% of the enzyme activity
To accurately evaluate the remaining ␥-secretase activity in
NCT ⫺/⫺ cells, we tried to establish a cell-free assay. However,
although we could readily detect ␥-secretase activity in solubilized membranes from wild-type cells, we failed to detect any
␥-secretase-like activity in solubilized membranes from NCT ⫺/⫺
cells (data not shown). It is likely that the trimeric ␥-secretase
complex lacking NCT is highly unstable in the detergent solution,

PS, NCT, Pen2, and Aph1 are the four proteins essential for reconstituting robust ␥-secretase activity (De Strooper, 2003; Iwatsubo,
2004; Spasic and Annaert, 2008). With the exception of PS, which
harbors the catalytic site of ␥-secretase, the precise contributions
of the other proteins to ␥-secretase activity remain unclear, and
PS remains the only GxGD protease that requires partners for its
protease activity. Here, we have provided direct evidence that
when PS1/Pen2/Aph1a are present, ␥-secretase can assemble and
acquire catalytic activity without NCT, cleaving both Notch and
APP (C99) substrates. Furthermore, this three-protein enzyme
remains biochemically similar to the four-protein enzyme: both
are DAPT and L-685,458 sensitive (Fig. 1 B), both generate NICD
at the S3 site (Figs. 1–3), and both cleave APP at  and ␥ to release
AICD and A␤40, respectively (Fig. 4). Importantly, ligandmediated activation of endogenous Notch can also be observed in
NCT ⫺/⫺ cells (Fig. 3B). However, this residual activity is not
sufficient to permit survival of NCT ⫺/⫺ embryos (Li et al., 2003;
Nguyen et al., 2006).
As this manuscript was being prepared, another group identified NCT-independent PS1 mutants (PS1 S438P or PS1 F411Y/
S438P) (Futai et al., 2009), suggesting that perhaps this S438P
mutation increased complex stability. We aligned PS proteins
with their homologues and found that a Pro residue is located at
a conserved position in TMD9 of SPP (P324; supplemental Fig. 5,
available at www.jneurosci.org as supplemental material), suggesting that the ␣-helix-breaking Pro residue may increase stability of GxGD proteases. Interestingly, this analysis revealed that
one of the two Caenorhabditis elegans PS proteins, Hop-1, also
contains a Pro at the homologous position (P329) whereas the
other (Sel-12) does not. Consistent with the hypothesis that
␥-secretase complexes centered around Hop-1 may have reduced
dependency on the Aph2/NCT gene (Goutte et al., 2000), Aph2/Hop-1 double mutants are strongly affected but Aph-2/Sel-12
double mutants are not (Francis et al., 2002). This result indicates
that Hop-1 is active without Aph-2, whereas Sel-12 is dependent
on Aph-2 for full activity. NCT has been proposed to play a role in
PS1 trafficking. In the absence of NCT, most PS1 proteins remain
in the endoplasmic reticulum; PS1-NTFs were undetectable at
the plasma membrane (Zhang et al., 2005). We have provided
indirect evidence that at least some PS1 NTF-containing
␥-secretase can reach the plasma membrane where it can activate
a ligand-dependent Notch signal in the absence of NCT. Coupled
with the genetic data (Francis et al., 2002) and with the analysis of
NCT mutants (Chavez-Gutierrez et al., 2008), these observations
favor a model in which NCT acts to stabilize ␥-secretase but is not
required for catalytic activity.
Although we cannot completely rule out the possibility that
NCT contributes to ␥-secretase activity and that this contribu-
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Figure 6. Pen2 and Aph1a are involved in the ␥-secretase activity in the absence of NCT. Representative Western blots of NICD levels in Pen2 and Aph1 siRNA-transfected NCTRR⫺/⫺ cells are
shown. A, Lysates from control (Ctr) siRNA- or Pen2 siRNA-transfected NCT ⫺/⫺ cells were analyzed by Western blotting. Pen2 siRNA markedly decreased PS1-NTF level but not that of full-length
PS1 (FL-PS1). Whereas Pen2 depletion slightly affected N1⌬E-6MT expression, it significantly diminished NICD generation in a dose-dependent manner. Note that the amounts of a PS1 fragment
(⬃30 kDa) increased in Pen2 siRNA-treated samples. This PS1 fragment does not have ␥-secretase activity. B, The efficiency of Pen2 knockdown (⬃90%) was confirmed by qRT-PCR. C, Depletion
of Aph1a in NCTRR⫺/⫺ cells markedly decreased PS1-NTF and NICD generation, whereas Aph1b siRNA treatment did not significantly affect NICD levels. D, Knockdown of Aph1b was confirmed by
qRT-PCR.

tion requires E333 (Dries et al., 2009), our findings indicate that
neither substrate recognition nor contribution to catalytic activity by NCT is necessary for ␥-secretase activity. A distinct property of ␥-secretase-mediated intramembrane cleavage is that it
requires prior ectodomain shedding of the substrate; the large
extracellular domain of NCT has been proposed to act as the
gatekeeper that measures the size of the substrate ectodomain
and the availability of a free N terminus (Hu et al., 2002; De
Strooper, 2005; Shah et al., 2005). However, we found that NCTdeficient ␥-secretase activity still requires prior ectodomain shedding of its substrates (Fig. 3) (Mumm et al., 2000). It is unlikely
that an unknown protein may function as NCT in NCT ⫺/⫺ cells,
and no additional NCT homologues have been found in the
mouse or C. elegans genome. Indeed, a substrate-binding site has
also been identified at the interface of PS1 NTF/CTF (Kornilova
et al., 2005); this site may also be sensitive to the presence of a
large extracellular domain. Additionally, the GxGD motif in

PS has been reported to contribute to substrate identification
(Yamasaki et al., 2006). Furthermore, a PS relative, SPPLP2,
requires substrate shedding yet does not require putative substrate binding partners (Martin et al., 2009).
How ␥-secretase assembly occurs is a critical question in
␥-secretase biology. One model posits that PS binds initially to
Aph1 and NCT to form a subcomplex, and then this subcomplex
binds to Pen2 to initiate PS endoproteolysis and NCT glycosylation (Takasugi et al., 2003). Alternatively, PS and Pen2 form a
subcomplex in which PS endoproteolysis occurs while NCT and
Aph1 form another subcomplex. The two subcomplexes then
bind together (Spasic and Annaert, 2008). In both models,
␥-secretase activity is conferred only after the complete assembly
of the four-protein complex. The observations reported here suggest that a trimeric complex containing PS1, Pen2, and Aph1a is
active but unstable and perhaps rapidly converted to the fourprotein complex in wild-type cells. Whether such a subcomplex
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occurs in the presence of NCT or only forms in its absence remains to be determined.
Why PS proteins require additional stabilizing components
whereas SPP and SPPL do not and why PS2 is unable to act
without NCT are interesting puzzles still to be resolved. The fact
that ␥-secretase activity could not be detected in PS DKO cells
(Figs. 1, 3, and 4) and that PS1 siRNA greatly diminished the
residual ␥-secretase activity in NCT ⫺/⫺ cells (Fig. 5A; supplemental Figs. 2 and 3, available at www.jneurosci.org as supplemental material for sequences) confirms the centrality of PS for
␥-secretase activity. Interestingly, although PS possesses both
substrate-binding and catalytic sites and thus has the potential to
act as an enzyme on its own, knockdown of Pen2 and Aph1a
eliminated ␥-secretase activity in NCT ⫺/⫺ cells (Fig. 6). Despite
establishing that PS requires these two proteins, the current data
cannot distinguish whether Pen2 and Aph1 are required for stabilizing PS1 or for enhancing its catalytic activity. If Aph1 or Pen2
are required only to stabilize PS1, it is conceivable that other
unstable trimeric ␥-secretase complexes can be formed in vitro. It
is intriguing to suggest that isolation of such an active trimeric
␥-secretase might facilitate the elucidation of its structure. It also
appears that active Hop-1 trimeric ␥-secretase complexes may
exist in vivo and can be isolated from Aph-2 mutants.
In conclusion, the present data demonstrate that NCT is dispensable for PS1-containing ␥-secretase activity and cell surface
transport but critical for stabilizing ␥-secretase. This study also
provides a biochemical explanation for the differential requirement for Aph2 shown by the two C. elegans PS proteins, Hop-1
and Sel-12.
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